Effects of rasagiline combined with levodopa and benserazide hydrochloride on motor function and homocysteine and IGF-1 levels in elderly patients with Parkinson’s disease

Overview of attention for article published in BMC Neurology, October 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

During the progression of the movement disorder, older patients with Parkinson disease may see changes in their insulin-like…

Une étude récente révèle que l’ajout de rasagiline (commercialisée sous le nom d’Azilect) au régime thérapeutique des personnes…

A recent study finds that the addition of rasagiline (marketed as Azilect) to the treatment regimen of individuals with…

A year of treatment with levodopa plus benserazide led to greater clinical improvements among Parkinson’s disease patients who…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.